meglumine and Depression, Endogenous

meglumine has been researched along with Depression, Endogenous in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bagot, RC; Berton, O; Cahill, ME; Dietz, DM; Fallon, B; Feng, J; Ferguson, D; Harrigan, E; Joshi, T; Ku, SM; Mazei-Robison, M; Nestler, EJ; Robison, AJ; Vialou, V; Winstanley, CA1
Faizullin, RM; Kalugina, AV; Malkin, MP; Miroshnichenko, IY; Pryakhina, KE; Rassokhina, LM; Volchegorskii, IA1
Pravdin, EV; Uzlova, TV; VolchegorskiÄ­, IA1
Adams, JB; Costa, J; Cutler, NR; Greiner, M; Pande, AC; Pierce, MW; Pyke, RE; Schweizer, E; Wilcox, CS; Wisselink, PG1

Trials

2 trial(s) available for meglumine and Depression, Endogenous

ArticleYear
[Effect of 3-oxypyridine and succinic acid derivatives on affective status in recrudescence of inflammatory diseases of uterus and its appendages].
    Eksperimental'naia i klinicheskaia farmakologiia, 2012, Volume: 75, Issue:11

    Topics: Adnexa Uteri; Adolescent; Adult; Antioxidants; Brain; Depressive Disorder; Female; Genital Diseases, Female; Humans; Inflammation; Interleukin-1beta; Meglumine; Middle Aged; Phagocytosis; Picolines; Prospective Studies; Pyridines; Recurrence; Succinates; Succinic Acid; Tumor Necrosis Factor-alpha; Uterus

2012
A double-blind, placebo-controlled study of a CCK-B receptor antagonist, CI-988, in patients with generalized anxiety disorder.
    Journal of clinical psychopharmacology, 1995, Volume: 15, Issue:6

    Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Colonic Diseases, Functional; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Indoles; Male; Meglumine; Panic Disorder; Personality Inventory; Phobic Disorders; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Somatoform Disorders; Treatment Outcome

1995

Other Studies

2 other study(ies) available for meglumine and Depression, Endogenous

ArticleYear
Prefrontal cortical circuit for depression- and anxiety-related behaviors mediated by cholecystokinin: role of ΔFosB.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2014, Mar-12, Volume: 34, Issue:11

    Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain Mapping; Cholecystokinin; Chronic Disease; Depressive Disorder; Indoles; Limbic System; Male; Meglumine; Mice; Mice, Inbred C57BL; Neural Pathways; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Receptor, Cholecystokinin B; Social Dominance; Stress, Psychological

2014
[Antidepressant effect of 3-oxypyridine and succinic acid derivatives (experimental study)].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2015, Volume: 115, Issue:2

    Topics: Animals; Behavior, Animal; Depressive Disorder; Disease Models, Animal; Female; Male; Meglumine; Picolines; Psychotropic Drugs; Pyridines; Rats; Succinates; Succinic Acid

2015